Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Acorda Therapeutics, Inc. (ACOR)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K/A10-K
Net income  -104.0-99.6-273.033.7-223.4-34.611.117.7
Depreciation and amortization   [+]34.041.334.611.523.221.615.08.5
Asset impairment charges   4.1277.6 296.8   
Stock-based compensation  3.08.114.321.332.836.433.529.4
Deferred taxes  -5.24.7-2.0-14.5-54.0-11.24.06.7
Change in working capital   [+]24.9-12.0-41.447.6-20.817.9-38.3-2.2
Other operating activities  5.9-7.6-138.251.342.5-0.413.314.6
Cash from operations  -41.3-61.0-128.2150.897.129.638.574.6
   
Capital expenditures  -0.2-4.4-90.4-33.3-13.7-6.2-5.9-5.1
Purchases of intangible assets  0.0  -0.6-0.7-0.9-1.1-2.7
Sales of short-term investments, net   [+] 63.889.9-150.8 199.8-78.2190.1
Other cash from investing  74.0  7.93.7-266.5 -476.2
Cash from investing  73.859.4-0.5-176.9-10.7-73.8-85.2-293.8
   
Issuance of common stock, net    -0.113.510.475.518.116.0
Financing costs   -1.1-4.7  -1.6 -7.5
Other cash from financing  -69.7-2.7-65.2-0.751.1-31.2-0.3329.8
Cash from financing  -69.7-1.7-60.612.861.545.917.8353.3
   
Free cash flow  -41.5-65.4-218.6117.583.423.532.669.6
        Per share (diluted)  ($3.91)($8.09)($27.58)$2.48$1.81$0.52$0.75$1.64
   
Cash paid for interest  0.06.76.16.16.16.17.24.5

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy